AbbVie (ABBV): 99.8% of its 52-week range
On 2026-10-12, AbbVie (ABBV) closed at 281.12 USD, up 1.68% on the day. At the 2026-10-12 close, AbbVie (ABBV) traded at 99.8% of its 52-week range. At the 2026-10-12 close, AbbVie (ABBV) had an RSI(14) of 75.16, in the 96th percentile of its history since 2013. Its 20-day return of +7.39% is in the 82nd percentile of its history since 2013. RSI above 70 is conventionally termed overbought. The AbbVie (ABBV) RSI last entered the overbought zone 3 days ago (2026-10-09) and the oversold zone 207 days ago (2026-03-19). It is trading above its 20-, 50- and 200-day moving averages. At the 2026-10-12 close, the 20/50/200-day moving averages of AbbVie (ABBV) were 266.27 / 259.5 / 232.91 USD, with price +5.58% / +8.33% / +20.70% against them. Ranked from highest to lowest, its moving averages are the 20-day, 50-day and 200-day. At the 2026-10-12 close, the 52-week range of AbbVie (ABBV) was 190.75–281.3 USD; it closed 0.06% below the high (0.0× its typical daily range) and 47.38% above the low (15.5× its typical daily range). The high was set today (2026-10-12) and the low 166 days ago (2026-04-29). It is 0.06% below its all-time high, set today (2026-10-12). Its 20-day volatility is 0.785% daily, in the 5th percentile of its history since 2013. Its daily realised volatility is 0.702% over 5 days, 0.785% over 20 days, 1.284% over 60 days and 1.602% over 120 days. Annualised, these are 11.1%, 12.5%, 20.4% and 25.4% respectively. Its 14-day average true range (ATR) is 5.84 USD, 2.08% of price. It has returned +5.78% (94th percentile since 2013) over 5 days, +5.57% (85th) over 10 days, +7.39% (82nd) over 20 days, +10.46% (71st) over 60 days, +37.05% (96th) over 120 days and +21.86% (62nd) over 252 days. Against the S&P 500, its weekly returns show a beta of -0.70 and a correlation of -0.30 over 52 weeks; over 26 weeks, a beta of -1.82 and a correlation of -0.54. Relative to the S&P 500, it has returned +5.35% (5-day), +3.97% (10-day), +4.93% (20-day), +5.78% (60-day) and +5.94% (252-day). Its weekly-return correlation with changes in the US 10-year TIPS real yield is -0.11 over 52 weeks and -0.03 over 26 weeks. Next earnings are scheduled for 2026-10-30.
Figures reflect the official regular-session close for 2026-10-12.
=== ABBVIE (ABBV) (USD) ===
price & change (as of 2026-10-12, prior 2026-10-09)
close 281.12
change +4.65 (+1.682%)
vs market S&P 500 -0.06% · Nasdaq 100 -0.70% (same day)
listing Exchange: NYSE, Currency: USD
range (as of 2026-10-12)
range 5.29
close pos 96.6% of range
moving averages (as of 2026-10-12)
20d MA 266.27 price above by +5.58%
50d MA 259.50 price above by +8.33%
200d MA 232.91 price above by +20.70%
200d MA slope +1.76% over 20 sessions (rising)
price > all MAs
stack: 20d > 50d > 200d
20d MA last crossed above 50d MA: 2026-05-27 (138d ago)
20d MA last crossed above 200d MA: 2026-06-22 (112d ago)
50d MA last crossed above 200d MA: 2026-07-09 (95d ago)
volatility (as of 2026-10-12)
20d stdev 0.785% daily ≈ 12.5% annualised (×√252) (5th pct of own history, since 2013 (3445 obs))
5d vol 0.702% daily ≈ 11.1% annualised (×√252) (17th pct of own history, since 2013 (3460 obs))
60d vol 1.284% daily ≈ 20.4% annualised (×√252) (27th pct of own history, since 2013 (3405 obs))
120d vol 1.602% daily ≈ 25.4% annualised (×√252) (56th pct of own history, since 2013 (3345 obs))
vs easing-2024 avg 0.49× (0.785% vs 1.599% era avg)
ATR (as of 2026-10-12)
ATR(14) 5.84
ATR% 2.08% (46th pct of own history, since 2013 (3451 obs))
range/ATR 90.6%
relative volume (as of 2026-10-12)
RVOL 1.24x (today vs prior 20-day average, excl. today)
pctile 81st pct of own history, since 2013 (3445 obs)
avg vol 63d 4,831,288 (≈3-month average daily share volume)
52-week range (as of 2026-10-12)
high 281.30 (-0.06% from high) [2026-10-12, 0d ago]
low 190.75 (+47.38% from low) [2026-04-29, 166d ago]
drawdown -0.06% from all-time high, 0d ago (2026-10-12)
max drawdown (10-year, close-basis) -48.88% (2018-01-26 123.21 -> 2019-08-15 62.98, 566d peak-to-trough); recovered 2021-12-09 (847d after trough)
momentum (as of 2026-10-12)
RSI(14) 75.16 (96th pct of own history, since 2013 (3451 obs))
last overbought 3d ago (2026-10-09)
last oversold 207d ago (2026-03-19)
MACD (as of 2026-10-12)
MACD(12,26,9) +4.27 (above signal) signal +2.84 hist +1.43
returns (as of 2026-10-12)
5d return +5.78% from 265.76 on 2026-10-05 (94th pct of own history, since 2013 (3460 obs))
10d return +5.57% from 266.28 on 2026-09-28 (85th pct of own history, since 2013 (3455 obs))
20d return +7.39% from 261.77 on 2026-09-14 (82nd pct of own history, since 2013 (3445 obs))
60d return +10.46% from 254.49 on 2026-07-17 (71st pct of own history, since 2013 (3405 obs))
120d return +37.05% from 205.12 on 2026-04-21 (96th pct of own history, since 2013 (3345 obs))
252d return +21.86% from 230.69 on 2025-10-09 (62nd pct of own history, since 2013 (3213 obs))
YTD return +23.03% from 228.49 on 2025-12-31
volatility by rate-era
ZIRP (2009–2015) 1.73% (from 2013-01-02)
tightening (2015–2018) 1.75%
ZIRP (2019–2021) 1.77%
tightening (2022–2023) 1.33%
easing (2024– ) 1.60%
real-yield sensitivity (weekly returns vs weekly Δ in 10Y TIPS real yield, DFII10) (as of 2026-10-08)
vs real yield (Δ) -0.03 (26w)
vs real yield (Δ) -0.11 (52w)
S&P 500 market factor (weekly returns) (as of 2026-10-12)
vs S&P 500 beta -1.82 corr -0.54 (26w)
vs S&P 500 beta -0.70 corr -0.30 (52w)
vs S&P 500 +5.35% rel (5d return)
vs S&P 500 +3.97% rel (10d return)
vs S&P 500 +4.93% rel (20d return)
vs S&P 500 +5.78% rel (60d return)
vs S&P 500 +5.94% rel (252d return)
vs Nasdaq 100 beta -1.15 corr -0.65 (26w)
vs Nasdaq 100 beta -0.66 corr -0.43 (52w)
vs Nasdaq 100 +7.12% rel (5d return)
vs Nasdaq 100 +4.28% rel (10d return)
vs Nasdaq 100 +2.19% rel (20d return)
vs Nasdaq 100 +3.17% rel (60d return)
vs Nasdaq 100 -0.30% rel (252d return)
vs XLV (Health Care) beta +1.54 corr +0.84 (26w)
vs XLV (Health Care) beta +1.22 corr +0.71 (52w)
vs XLV +3.02% rel (5d return)
vs XLV +5.15% rel (10d return)
vs XLV +4.86% rel (20d return)
vs XLV +3.70% rel (60d return)
vs XLV +2.58% rel (252d return)
earnings horizon
next earnings 2026-10-30 (18 days)